Corneal deposition after high-dose chlorpromazine hydrochloride therapy

Cornea

Volumn 20, Issue 2, 2001, Pages 217-219

  Webber, S K ^a   Domniz, Y ^a   Sutton, G L ^a   Rogers, C M ^a   Lawless, M A ^a  

^a Sydney Refractive Surgery Centre   (Austria)

Author keywords

Cumulative dose; Phenothiazine

Indexed keywords

CHLORPROMAZINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA DISEASE; DRUG MEGADOSE; DRUG SAFETY; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISCOLORATION;

ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CORNEA; CORNEAL OPACITY; HUMANS; MALE; MIDDLE AGED; PIGMENTATION DISORDERS; SCHIZOPHRENIA; SKIN; SKIN PIGMENTATION; VISUAL ACUITY;

EID: 0035113912     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200103000-00023     Document Type: Article

References (9)

1. Ocular changes occurring with prolonged high dose chlorpromazine therapy: Results from a collaborative study
2. Cutaneous and ocular changes associated with the use of chlorpromazine
3. Chlorpromazine-induced corneal endothelial phototoxicity
4. Asymmetric anterior segment changes induced by chlorpromazine
5. Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes
6. Total dosage of chlorpromazine and ocular opacities
7. Chlorpromazine-induced retinopathy
8. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenicquantification procedures
9. Replacement of chlorpromazine with other neuroleptics: Effect on abnormal skin pigmentation and ocular changes